Calpain 1 cleaves and inactivates prostacyclin synthase in mesenteric arteries from diabetic mice

Abstract

Diabetes is associated with a number of co-morbidities including an increased risk of developing cardiovascular diseases. The activation of Ca-activated proteases of the calpain family has been implicated in platelet activation associated with diabetes and this study aimed to determine the role of calpain activation in the development of endothelial dysfunction. Diabetes induction in mice attenuated acetylcholine-induced relaxation of mesenteric artery rings, an effect prevented in mice receiving a calpain inhibitor. A nitric oxide-independent but diclofenac-sensitive component of the relaxation-response was altered and correlated with a loss of prostacyclin (PGI) generation and reduced vascular levels of PGI synthase. Calpain inhibition was also able to restore PGI synthase levels and PGI generation in arteries from diabetic animals. The effects of diabetes were reproduced in vitro by a combination of high glucose and palmitate, which elicited calpain activation, PGI synthase cleavage and inactivation as well as endothelial dysfunction in mesenteric arteries from wild-type mice. PGI cleavage was not observed in arteries from calpain 1 mice or mice overexpressing the endogenous calpain inhibitor calpastatin. Finally, proteomic analyses revealed that calpain 1 cleaved the C-terminal domain of PGI synthase close to the catalytic site of the enzyme. These data demonstrate that diabetes leads to the activation of calpain 1 in mesenteric arteries and can initiate endothelial dysfunction by cleaving and inactivating the PGI synthase. Given that calpain inhibition prevented diabetes-induced endothelial dysfunction in mesenteric arteries, calpains represent an interesting therapeutic target for the prevention of cardiovascular complication of diabetes.

Melatonin attenuates renal fibrosis in diabetic mice by activating the AMPK/PGC1α signaling pathway and rescuing mitochondrial function

“…Melatonin activates the AMPK/PGCα1 pathway to preserve mitochondrial function and structure in vitro. Besides mitochondrial apoptosis, mitochondrial function and structure are essential for cellular viability (10,50). The primary function of mitochondria is to supply sufficient energy for cellular metabolism.…”

“…Recently, several studies have documented the involvement of melatonin in kidney protection (9). Melatonin presumably enters mitochondria through melatonin receptor-dependent and -independent manners (10,11). Measurement of the sub-cellular distribution of melatonin revealed that the concentration of melatonin in mitochondria greatly exceeds that in blood (12), thus suggesting that melatonin may specifically target mitochondria.…”

Hyperglycaemia Stress-Induced Renal Injury is Caused by Extensive Mitochondrial Fragmentation, Attenuated MKP1 Signalling, and Activated JNK-CaMKII-Fis1 Biological Axis

“…The concentration of inflammation factors such as TNFα, MCP-1 and IL-6 were determined via ELISA (Cusabio Technology, Wuhan, China). The renal function was measured via analysing the levels of creatinine and blood urea nitrogen (BUN) using a Cobas® C311 Autoanalyzer (Roche Diagnostics, Indianapolis, USA) as per the manufacturer's protocols [26].…”

NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy

“…In response to mitochondrial fission, mitochondria could employ lysosomes via Parkin to degrade damaged mitochondria and maintain a healthy mitochondrial population, which is essential for cell survival [18][19][20]. Notably, the impairment of Parkin-mediated mitophagy is a feature of DN, and various pharmacological activators of mitophagy have been shown to protect against glomerulosclerosis and proteinuria, renal hypertrophy, and mesangial expansion in rodent DN models [21][22][23]. However, the regulatory signaling upstream of mitophagy is far from clear.…”